Documentos relacionados

1. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
2. Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis.
3. Correspondence on 'Standardisation of myositis-specific antibodies: where are we today?'
4. Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis.
5. From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies.
6. Juvenile dermatomyositis. Where are we now?
7. [Advances in the diagnostics and treatment of juvenile dermatomyositis].
8. Clinical heterogeneities and prognoses of patients with myositis specific antibody negative dermatomyositis: a retrospective study in China.
9. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase.
10. Characteristics of patients with juvenile dermatomyositis from 2001-2021 at a tertiary care center.